273 related articles for article (PubMed ID: 13678420)
1. Protease-activated receptor-4 uses dual prolines and an anionic retention motif for thrombin recognition and cleavage.
Jacques SL; Kuliopulos A
Biochem J; 2003 Dec; 376(Pt 3):733-40. PubMed ID: 13678420
[TBL] [Abstract][Full Text] [Related]
2. Protease-activated receptor 4 uses anionic residues to interact with alpha-thrombin in the absence or presence of protease-activated receptor 1.
Nieman MT
Biochemistry; 2008 Dec; 47(50):13279-86. PubMed ID: 19053259
[TBL] [Abstract][Full Text] [Related]
3. Interaction of thrombin with PAR1 and PAR4 at the thrombin cleavage site.
Nieman MT; Schmaier AH
Biochemistry; 2007 Jul; 46(29):8603-10. PubMed ID: 17595115
[TBL] [Abstract][Full Text] [Related]
4. Substrate-assisted catalysis of the PAR1 thrombin receptor. Enhancement of macromolecular association and cleavage.
Jacques SL; LeMasurier M; Sheridan PJ; Seeley SK; Kuliopulos A
J Biol Chem; 2000 Dec; 275(52):40671-8. PubMed ID: 11005807
[TBL] [Abstract][Full Text] [Related]
5. Protease-activated receptor 1 (PAR1) and PAR4 heterodimers are required for PAR1-enhanced cleavage of PAR4 by α-thrombin.
Arachiche A; Mumaw MM; de la Fuente M; Nieman MT
J Biol Chem; 2013 Nov; 288(45):32553-32562. PubMed ID: 24097976
[TBL] [Abstract][Full Text] [Related]
6. Proteolysis of the exodomain of recombinant protease-activated receptors: prediction of receptor activation or inactivation by MALDI mass spectrometry.
Loew D; Perrault C; Morales M; Moog S; Ravanat C; Schuhler S; Arcone R; Pietropaolo C; Cazenave JP; van Dorsselaer A; Lanza F
Biochemistry; 2000 Sep; 39(35):10812-22. PubMed ID: 10978167
[TBL] [Abstract][Full Text] [Related]
7. Molecular mapping of thrombin-receptor interactions.
Ayala YM; Cantwell AM; Rose T; Bush LA; Arosio D; Di Cera E
Proteins; 2001 Nov; 45(2):107-16. PubMed ID: 11562940
[TBL] [Abstract][Full Text] [Related]
8. Protease-activated receptor 4-like peptides bind to thrombin through an optimized interaction with the enzyme active site surface.
Cleary DB; Trumbo TA; Maurer MC
Arch Biochem Biophys; 2002 Jul; 403(2):179-88. PubMed ID: 12139967
[TBL] [Abstract][Full Text] [Related]
9. Crystal structures of murine thrombin in complex with the extracellular fragments of murine protease-activated receptors PAR3 and PAR4.
Bah A; Chen Z; Bush-Pelc LA; Mathews FS; Di Cera E
Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11603-8. PubMed ID: 17606903
[TBL] [Abstract][Full Text] [Related]
10. Plasmin desensitization of the PAR1 thrombin receptor: kinetics, sites of truncation, and implications for thrombolytic therapy.
Kuliopulos A; Covic L; Seeley SK; Sheridan PJ; Helin J; Costello CE
Biochemistry; 1999 Apr; 38(14):4572-85. PubMed ID: 10194379
[TBL] [Abstract][Full Text] [Related]
11. Protease-activated receptors 1 and 4 are shut off with distinct kinetics after activation by thrombin.
Shapiro MJ; Weiss EJ; Faruqi TR; Coughlin SR
J Biol Chem; 2000 Aug; 275(33):25216-21. PubMed ID: 10837487
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil proteases can inactivate human PAR3 and abolish the co-receptor function of PAR3 on murine platelets.
Cumashi A; Ansuini H; Celli N; De Blasi A; O'Brien PJ; Brass LF; Molino M
Thromb Haemost; 2001 Mar; 85(3):533-8. PubMed ID: 11307827
[TBL] [Abstract][Full Text] [Related]
13. Blocking the protease-activated receptor 1-4 heterodimer in platelet-mediated thrombosis.
Leger AJ; Jacques SL; Badar J; Kaneider NC; Derian CK; Andrade-Gordon P; Covic L; Kuliopulos A
Circulation; 2006 Mar; 113(9):1244-54. PubMed ID: 16505172
[TBL] [Abstract][Full Text] [Related]
14. A cluster of aspartic residues in the extracellular loop II of PAR 4 is important for thrombin interaction and activation of platelets.
Sánchez Centellas D; Gudlur S; Vicente-Carrillo A; Ramström S; Lindahl TL
Thromb Res; 2017 Jun; 154():84-92. PubMed ID: 28448853
[TBL] [Abstract][Full Text] [Related]
15. Mapping the interaction of bradykinin 1-5 with the exodomain of human protease activated receptor 4.
Nieman MT; Pagan-Ramos E; Warnock M; Krijanovski Y; Hasan AA; Schmaier AH
FEBS Lett; 2005 Jan; 579(1):25-9. PubMed ID: 15620686
[TBL] [Abstract][Full Text] [Related]
16. Biphasic kinetics of activation and signaling for PAR1 and PAR4 thrombin receptors in platelets.
Covic L; Gresser AL; Kuliopulos A
Biochemistry; 2000 May; 39(18):5458-67. PubMed ID: 10820018
[TBL] [Abstract][Full Text] [Related]
17. Structure-function analysis of protease-activated receptor 4 tethered ligand peptides. Determinants of specificity and utility in assays of receptor function.
Faruqi TR; Weiss EJ; Shapiro MJ; Huang W; Coughlin SR
J Biol Chem; 2000 Jun; 275(26):19728-34. PubMed ID: 10779527
[TBL] [Abstract][Full Text] [Related]
18. Thrombin-induced platelet activation via PAR4: pivotal role for exosite II.
Boknäs N; Faxälv L; Sanchez Centellas D; Wallstedt M; Ramström S; Grenegård M; Lindahl TL
Thromb Haemost; 2014 Sep; 112(3):558-65. PubMed ID: 24990072
[TBL] [Abstract][Full Text] [Related]
19. Contributions of Protease-Activated Receptors PAR1 and PAR4 to Thrombin-Induced GPIIbIIIa Activation in Human Platelets.
Duvernay MT; Temple KJ; Maeng JG; Blobaum AL; Stauffer SR; Lindsley CW; Hamm HE
Mol Pharmacol; 2017 Jan; 91(1):39-47. PubMed ID: 27784794
[TBL] [Abstract][Full Text] [Related]
20. Proteinase-activated receptors (PARs)--the PAR3 Neo-N-terminal peptide TFRGAP interacts with PAR1.
Kaufmann R; Schulze B; Krause G; Mayr LM; Settmacher U; Henklein P
Regul Pept; 2005 Feb; 125(1-3):61-6. PubMed ID: 15582715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
